You have 9 free searches left this month | for more free features.

Multiple Nevi

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Helicobacter Pylori Infection Trial in Chang chun (TNP-2198, Rabeprazole Sodium, Amoxicillin)

Completed
  • Helicobacter Pylori Infection
  • Chang chun, Jilin, China
    The First Hospital of Jilin University
Oct 7, 2023

Asthma Trial (XKH001 Injection, XKH001 Placebo Injection)

Not yet recruiting
  • Asthma
  • XKH001 Injection
  • XKH001 Placebo Injection
  • (no location specified)
Aug 13, 2023

Multiple Sclerosis Trial in Hamburg (levidex, Control, treatment as usual (TAU))

Not yet recruiting
  • Multiple Sclerosis
  • levidex
  • +2 more
  • Hamburg, Germany
    GAIA AG
Oct 19, 2023

Rheumatoid Arthritis, Systemic Lupus Erythematosus Trial (GS-0272, Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • (no location specified)
Sep 4, 2023

Drug Drug Interaction Trial in Porto (Givinostat)

Completed
  • Drug Drug Interaction
  • Porto, Portugal
    Hospital da Prelada, 3rd Floor & East Wing 4th Floor Rua Sarment
May 5, 2023

Allergic Rhinitis Due to Weed Pollen, Allergic Rhinitis Trial in Melbourne (INI-2004, Placebo)

Recruiting
  • Allergic Rhinitis Due to Weed Pollen
  • Allergic Rhinitis
  • Melbourne, Victoria, Australia
    Nucleus Network Pty Ltd
Sep 7, 2023

Prognosis Based on cfDNA Methylation in Multiple Myeloma

Recruiting
  • Multiple Myeloma
  • cfDNA methylation assessment
  • Tianjin, Tianjin, China
    National Clinical Research Center for Blood Diseases, Blood Dise
Jan 11, 2023

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix, Jacksonville, Rochester

Recruiting
  • Plasma Cell Myeloma
  • +3 more
  • Bone Marrow Biopsy
  • +3 more
  • Phoenix, Arizona
  • +2 more
Jan 18, 2023

Mitochondrial Dysfunction in Primary Progressive Multiple

Recruiting
  • Multiple Sclerosis
    • Milan, MI, Italy
    • +1 more
    Aug 29, 2023

    Hepatitis B, Chronic Trial in Jilin (AHB-137 injection, Placebo)

    Recruiting
    • Hepatitis B, Chronic
    • AHB-137 injection
    • Placebo
    • Jilin, China
      The First Hospital of Jilin University
    Nov 2, 2023

    Atherosclerotic Cardiovascular Disease Trial (YN001, Placebo for YN001, rosuvastatin calcium tablets)

    Not yet recruiting
    • Atherosclerotic Cardiovascular Disease
    • (no location specified)
    Sep 21, 2023

    Multiple Sclerosis, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)

    Not yet recruiting
    • Multiple Sclerosis
    • +2 more
    • Patient Participation Form
    • (no location specified)
    Feb 25, 2023

    Healthy Trial in Alcorcón (Mechanical Conditioning stimulus)

    Recruiting
    • Healthy
    • Mechanical Conditioning stimulus
    • Alcorcón, Madrid, Spain
      Universidad Rey Juan Carlos
    Feb 15, 2023

    Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)

    Not yet recruiting
    • Multiple Myeloma
    • Myeloma-Associated Amyloidosis
    • Saint Louis, Missouri
      Washington University School of Medicine
    Apr 6, 2023

    Multiple Myeloma Trial in Duarte (Biospecimen Collection, Bone Marrow Aspiration, Computed Tomography)

    Recruiting
    • Multiple Myeloma
    • Biospecimen Collection
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Sep 21, 2023

    Orofacial Pain in Multiple Sclerosis

    Recruiting
    • Multiple Sclerosis
    • Diagnosis of pain
    • Varaždin, Croatia
      Varazdin General Hospital
    Sep 5, 2023

    Smoldering Multiple Myeloma Trial (Selinexor)

    Not yet recruiting
    • Smoldering Multiple Myeloma
    • (no location specified)
    Oct 27, 2022

    Determine the Optimal Initial Therapy for Multiple Myeloma

    Recruiting
    • Multiple Myeloma
    • Non-Interventional Study
    • Scottsdale, Arizona
    • +3 more
    Nov 22, 2023

    Drug Interaction Trial in Beijing (ZX-7101A, Oseltamivir, ZX-7101A and Oseltamivir)

    Recruiting
    • Drug Interaction
    • Beijing, Beijing, China
      Peking University Third Hospital
    Sep 21, 2023

    Elranatamab, Myeloma, Multiple Myeloma Trial in China (Elranatamab)

    Recruiting
    • Elranatamab
    • +10 more
    • Fuzhou, Fujian, China
    • +18 more
    Jan 18, 2023

    Hemophilia A Trial (NXT007)

    Not yet recruiting
    • Hemophilia A
    • (no location specified)
    Aug 4, 2023

    Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Sumida City (CCX168, Placebo)

    Completed
    • Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
    • Sumida City, Tokyo, Japan
      Sumida Hospital, SOUSEIKAI Global Clinical Research Center
    Aug 4, 2023

    Multiple Myeloma Trial in Tucson (Immediate yoga intervention, Delayed yoga intervention)

    Not yet recruiting
    • Multiple Myeloma
    • Immediate yoga intervention
    • Delayed yoga intervention
    • Tucson, Arizona
      University of Arizona Cancer Center
    Sep 27, 2023

    Aromatherapy, Randomized Controlled Trial, Multiple Sclerosis Trial in Erzurum (lavender oil)

    Active, not recruiting
    • Aromatherapy
    • +2 more
    • lavender oil
    • Erzurum, Turkey
      Ataturk Unıversity
    Jun 29, 2023

    Ofatumumab in Portuguese Multiple Sclerosis Patients

    Not yet recruiting
    • Relapsing Multiple Sclerosis
    • Ofatumumab
    • (no location specified)
    Mar 30, 2023